INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 264 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,566,758 | +167985.4% | 905,126 | +180925.2% | 0.10% | – |
| Q2 2023 | $20,565 | -99.3% | 500 | -98.9% | 0.00% | -100.0% |
| Q1 2021 | $3,135,000 | -77.4% | 45,377 | -80.9% | 0.02% | -79.5% |
| Q4 2019 | $13,845,000 | -71.0% | 237,554 | -70.1% | 0.07% | -75.1% |
| Q3 2019 | $47,703,000 | +113.9% | 794,128 | +98.9% | 0.29% | +150.4% |
| Q2 2019 | $22,301,000 | +198.8% | 399,294 | +198.1% | 0.12% | +244.1% |
| Q1 2019 | $7,464,000 | +52.7% | 133,959 | +23.6% | 0.03% | +41.7% |
| Q4 2018 | $4,889,000 | -43.0% | 108,393 | +8.4% | 0.02% | -60.0% |
| Q4 2016 | $8,579,000 | +3.9% | 100,000 | 0.0% | 0.06% | +3.4% |
| Q3 2016 | $8,255,000 | -60.0% | 100,000 | -61.3% | 0.06% | -58.6% |
| Q2 2016 | $20,615,000 | -29.7% | 258,400 | -40.7% | 0.14% | -37.8% |
| Q1 2016 | $29,329,000 | +6.8% | 435,400 | +7.5% | 0.22% | -0.4% |
| Q4 2015 | $27,458,000 | +1.7% | 405,100 | -10.7% | 0.23% | +6.6% |
| Q3 2015 | $27,000,000 | – | 453,400 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |